Sonpavde, G: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Precision medicine for metastatic renal cell carcinoma11Disclosures: Guru Sonpavde, MD: Research support from Novartis, Pfizer, and speaker or advisory board for Novartis, Pfizer, and GSK. Toni K. Choueiri, MD: Research support from Pfizer. Advisory board: Pfizer, Novartis, Aveo, GSK, Bayer/Onyx, and Genentech. No speakers bureau.

Sonpavde, Guru, Choueiri, Toni K.

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2014

Language:

english

File:

PDF, 591 KB

english, 2014

2

Treatment-related mortality with vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy in patients with advanced solid tumors: A meta-analysis

Shanthi Sivendran, Ziyue Liu, Louis J. Portas Jr, Menggang Yu, Noah Hahn, Guru Sonpavde, William K. Oh, Matthew D. Galsky

Journal:

Cancer Treatment Reviews

Year:

2012

Language:

english

File:

PDF, 298 KB

english, 2012

3

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

Nuhn, Philipp, De Bono, Johann S., Fizazi, Karim, Freedland, Stephen J., Grilli, Maurizio, Kantoff, Philip W., Sonpavde, Guru, Sternberg, Cora N., Yegnasubramanian, Srinivasan, Antonarakis, Emmanuel S

Journal:

European Urology

Year:

2018

Language:

english

File:

PDF, 650 KB

english, 2018

4

Improving the Cost Efficiency of PD-1/PD-L1 Inhibitors for Advanced Urothelial Carcinoma: A Major Role for Precision Medicine?

Sonpavde, Guru, Dranitsaris, George, Necchi, Andrea

Journal:

European Urology

Year:

2018

Language:

english

File:

PDF, 130 KB

english, 2018

5

The effect of treatment at minority-serving hospitals on outcomes for bladder cancer

Fletcher, Sean A., Gild, Philipp, Cole, Alexander P., Vetterlein, Malte W., Kibel, Adam S., Choueiri, Toni K., Sonpavde, Guru P., Preston, Mark A., Pucheril, Daniel, Menon, Mani, Sun, Maxine, Lipsitz,

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2018

Language:

english

File:

PDF, 430 KB

english, 2018

6

Impact of prednisone on toxicities and survival in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of randomized clinical trials

Morgan, Charity J., Oh, William K., Naik, Gurudatta, Galsky, Matthew D., Sonpavde, Guru

Journal:

Critical Reviews in Oncology/Hematology

Year:

2014

Language:

english

File:

PDF, 1.30 MB

english, 2014

7

Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials

Ghatalia, Pooja, Morgan, Charity J., Sonpavde, Guru

Journal:

Critical Reviews in Oncology/Hematology

Year:

2016

Language:

english

File:

PDF, 2.17 MB

english, 2016

8

Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder Cancer

Eich, Marie-Lisa, Rodriguez Pena, Maria Del Carmen, Chandrashekar, Darshan Shimoga, Chaux, Alcides, Agarwal, Sumit, Gordetsky, Jennifer B., Ferguson, James E., Sonpavde, Guru P., Netto, George J., Var

Journal:

Translational Oncology

Year:

2019

Language:

english

File:

PDF, 768 KB

english, 2019

9

Management of Castrate Resistant Prostate Cancer—Recent Advances and Optimal Sequence of Treatments

Zhang, Tian Yi, Agarwal, Neeraj, Sonpavde, Guru, DiLorenzo, Giuseppe, Bellmunt, Joaquim, Vogelzang, Nicholas J.

Journal:

Current Urology Reports

Year:

2013

Language:

english

File:

PDF, 265 KB

english, 2013

10

Emerging Systemic Therapies for the Management of Penile Cancer

Gupta, Shilpa, Sonpavde, Guru

Journal:

Urologic Clinics of North America

Year:

2016

Language:

english

File:

PDF, 612 KB

english, 2016

11

Utility of cell-free nucleic acid and circulating tumor cell analyses in prostate cancer

Gourdin, Theodore, Sonpavde, Guru

Journal:

Asian Journal of Andrology

Year:

2018

Language:

english

File:

PDF, 578 KB

english, 2018

12

Evaluating the cost of surveillance for non-muscle invasive bladder cancer: An economic analysis based on risk categories

Mossanen, M., Wang, Y., Szymaniak, J., Tan, W.S., Huynh, M.J., Preston, M.A., Trinh, Q-D., Sonpavde, G., Schrag, D., Kibel, A.S., Chang, S.L.

Journal:

European Urology Supplements

Year:

2019

File:

PDF, 86 KB

2019

13

Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)

Necchi, Andrea, Sonpavde, Guru, Lo Vullo, Salvatore, Giardiello, Daniele, Bamias, Aristotelis, Crabb, Simon J., Harshman, Lauren C., Bellmunt, Joaquim, De Giorgi, Ugo, Sternberg, Cora N., Cerbone, Lin

Journal:

European Urology

Year:

2017

Language:

english

File:

PDF, 1.34 MB

english, 2017

14

Re: Immediate Versus Deferred Chemotherapy After Radical Cystectomy in Patients with pT3-pT4 or N+ M0 Urothelial Carcinoma of the Bladder (EORTC 30994): An Intergroup, Open-label, Randomised Phase 3 Trial

Sonpavde, Guru, Pal, Sumanta

Journal:

European Urology

Year:

2016

Language:

english

File:

PDF, 71 KB

english, 2016

15

Trends in the Use of Cytoreductive Nephrectomy in the United States

Che-Kai Tsao, Alexander C. Small, Erin L. Moshier, Benjamin A. Gartrell, Juan P. Wisnivesky, Guru Sonpavde, James H. Godbold, Michael A. Palese, Simon J. Hall, William K. Oh, Matthew D. Galsky

Journal:

Clinical Genitourinary Cancer

Year:

2012

Language:

english

File:

PDF, 282 KB

english, 2012

16

A new approach to second-line therapy for urothelial cancer?

Sonpavde, Guru, Galsky, Matthew D, Bellmunt, Joaquim

Journal:

The Lancet Oncology

Year:

2013

Language:

english

File:

PDF, 217 KB

english, 2013

17

Enzastaurin shows preclinical antitumor activity against human transitional cell carcinoma and enhances the activity of gemcitabine

Jian, W., Yamashita, H., Levitt, J. M., Lerner, S. P., Sonpavde, G.

Journal:

Molecular Cancer Therapeutics

Year:

2009

Language:

english

File:

PDF, 510 KB

english, 2009

18

2624 The effectiveness of chemotherapy in “real world” patients with metastatic bladder cancer

Galsky, M.D., Pal, S.K., Lin, S.W., Ogale, S., Simpson, J., Schiff, C., Sonpavde, G.

Journal:

European Journal of Cancer

Year:

2015

Language:

english

File:

PDF, 72 KB

english, 2015

19

PD-1 and PD-L1 Inhibitors as Salvage Therapy for Urothelial Carcinoma

Journal:

New England Journal of Medicine

Year:

2017

Language:

english

File:

PDF, 106 KB

english, 2017

20

From the uncertainties to the evidence: a brief history of immunotherapy as the salvage therapy for advanced bladder cancer through a meta-analysis

Necchi, A., Raggi, D., Giannatempo, P., Sonpavde, G., Galsky, M.D., Bellmunt, J., Mariani, L., Miceli, R.

Journal:

Clinical Genitourinary Cancer

Year:

2017

Language:

english

File:

PDF, 4.36 MB

english, 2017

21

Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy

Sonpavde, Guru, Pond, Gregory Russell, Rosenberg, Jonathan E., Choueiri, Toni K., Bellmunt, Joaquim, Regazzi, Ashley Marie, Mullane, Stephanie A., Necchi, Andrea, Raggi, Daniele, Lee, Jae-Lyun, Lee, S

Journal:

Clinical Genitourinary Cancer

Year:

2018

Language:

english

File:

PDF, 450 KB

english, 2018

22

Gene expression in primary and metastatic kidney cancer to discover drivers of metastasis and targets for drug development

Zhao, Amy, Guru, Arjun, Guru, Sonpavde, Yang, Eddy, Li, Yufeng

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2015

Language:

english

File:

PDF, 209 KB

english, 2015

23

Phase II Trial of Sunitinib for the Therapy of Progressive Metastatic Castration-Refractory Prostate Cancer After Previous Docetaxel Chemotherapy

Guru Sonpavde, Thomas E. Hutson, William R. Berry, Kristi A. Boehm, Lina Asmar

Journal:

Clinical Genitourinary Cancer

Year:

2008

Language:

english

File:

PDF, 93 KB

english, 2008

24

A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer

Joshua J. Meeks, Joaquim Bellmunt, Bernard H. Bochner, Noel W. Clarke, Siamak Daneshmand, Matthew D. Galsky, Noah M. Hahn, Seth P. Lerner, Malcolm Mason, Thomas Powles, Cora N. Sternberg, Guru Sonpavd

Journal:

European Urology

Year:

2012

Language:

english

File:

PDF, 635 KB

english, 2012

25

Pooled Analysis of Phase II Trials Evaluating Weekly or Conventional Cisplatin as First-Line Therapy for Advanced Urothelial Carcinoma

Maughan, Benjamin L., Agarwal, Neeraj, Hussain, Syed A., Boucher, Kenneth M., Von Der Maase, Hans, Kaufman, Donald S., Lorusso, Vito, Moore, Malcolm J., Galsky, Matthew D., Sonpavde, Guru

Journal:

Clinical Genitourinary Cancer

Year:

2013

Language:

english

File:

PDF, 243 KB

english, 2013

26

Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials

Sonpavde, Guru, Pond, Gregory R., Fougeray, Ronan, Choueiri, Toni K., Qu, Angela Q., Vaughn, David J., Niegisch, Guenter, Albers, Peter, James, Nicholas D., Wong, Yu-Ning, Ko, Yoo-Joung, Sridhar, Srik

Journal:

European Urology

Year:

2013

Language:

english

File:

PDF, 380 KB

english, 2013

27

pT3 Substaging is a Prognostic Indicator for Lymph Node Negative Urothelial Carcinoma of the Bladder

Tilki, Derya, Svatek, Robert S., Karakiewicz, Pierre I., Novara, Giacomo, Seitz, Michael, Sonpavde, Guru, Gupta, Amit, Kassouf, Wassim, Fradet, Yves, Ficarra, Vincenzo, Skinner, Eila, Lotan, Yair, Sag

Journal:

The Journal of Urology

Year:

2010

Language:

english

File:

PDF, 419 KB

english, 2010

28

Objective Measures of Physical Functional Capacity Warrant Exploration to Complement or Replace the Subjective Physician Estimated Performance Status

Sonpavde, Guru, Vogelzang, Nicholas J., Galsky, Matthew D., Raghavan, Vasudevan A., Daniel, Suresh

Journal:

American Journal of Clinical Oncology

Year:

2012

Language:

english

File:

PDF, 92 KB

english, 2012

29

Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options

Gartrell, Benjamin A., Coleman, Robert, Efstathiou, Eleni, Fizazi, Karim, Logothetis, Christopher J., Smith, Matthew R., Sonpavde, Guru, Sartor, Oliver, Saad, Fred

Journal:

European Urology

Year:

2015

Language:

english

File:

PDF, 347 KB

english, 2015

30

Chemotherapy for Muscle-Invasive Bladder Cancer: Better Late Than Never?

Sonpavde, G., Gordetsky, J. B., Lockhart, M. E., Nix, J. W.

Journal:

Journal of Clinical Oncology

Year:

2016

Language:

english

File:

PDF, 601 KB

english, 2016

31

Drug development in prostate cancer: time to embrace RECIST?

Sonpavde, Guru, Armstrong, Andrew J

Journal:

The Lancet Oncology

Year:

2017

Language:

english

File:

PDF, 128 KB

english, 2017

32

Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study

Necchi, Andrea, Pond, Gregory R., Smaldone, Marc C., Pal, Sumanta K., Chan, Kevin, Wong, Yu-Ning, Viterbo, Rosalia, Sonpavde, Guru, Harshman, Lauren C., Crabb, Simon, Alva, Ajjai, Chowdhury, Simon, De

Journal:

European Urology Focus

Year:

2017

Language:

english

File:

PDF, 487 KB

english, 2017

33

A phase 1b dose-escalation study of TRC105 (endoglin antibody) in combination with axitinib in patients with metastatic renal cell carcinoma (mRCC)

Choueiri, T., Michaelson, M.D., Posadas, E., Sonpavde, G., McDermott, D., Seon, B., Jivani, M., Shazer, R., Adams, B., Theuer, C.

Journal:

Annals of Oncology

Year:

2016

Language:

english

File:

PDF, 37 KB

english, 2016

34

What to do when you discover testicular cancer

Sonpavde, Guru, Einhorn, Lawrence H.

Journal:

Postgraduate Medicine

Year:

1999

File:

PDF, 1.93 MB

1999

35

Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histological subtype matter?

Berg, S., D’Andrea, D., Vetterlein, M.W., Cole, A.P., Fletcher, S.A., Krimphove, M.J., Marchese, M., Lipsitz, S.R., Sonpavde, G., Noldus, J., Shariat, S.F., Kibel, A.S., Trinh, Q-D., Mossanen, M.

Journal:

European Urology Supplements

Year:

2019

Language:

english

File:

PDF, 420 KB

english, 2019

36

1297PImmune-related adverse events (irAEs) with single-agent PD-1 vs PD-L1 inhibitors: A meta-analysis of 8,730 patients from clinical trials

Sonpavde, G P, Grivas, P, Lin, Y, Hennessy, D, Hunt, J D

Journal:

Annals of Oncology

Year:

2019

File:

PDF, 81 KB

2019

37

Trends in adherence to thromboprophylaxis guideline in patients undergoing radical cystectomy

Tully, Karl H., Krimphove, Marieke J., Reese, Stephen W., Kibel, Adam S., Noldus, Joachim, Krasnow, Ross E., Trinh, Quoc-Dien, Sonpavde, Guru P., Chang, Steven L., Mossanen, Matthew

Journal:

Year:

2019

Language:

english

File:

PDF, 872 KB

english, 2019

38

Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Nonâmuscle-invasive Bladder Cancer

Tully, Karl H., Roghmann, Florian, Noldus, Joachim, Chen, Xi, HÃ¤user, Lorine, Kibel, Adam S., Sonpavde, Guru P., Mossanen, Matthew, Trinh, Quoc-Dien

Journal:

Clinical Genitourinary Cancer

Year:

2020

File:

PDF, 1.32 MB

2020

39

Quality of pathologic response and surgery correlate with survival for patients with completely resected bladder cancer after neoadjuvant chemotherapy

Guru Sonpavde, Bryan H. Goldman, V. O. Speights, Seth P. Lerner, David P. Wood, Nicholas J. Vogelzang, Donald L. Trump, Ronald B. Natale, H. Barton Grossman, E. David Crawford

Journal:

Year:

2009

Language:

english

File:

PDF, 188 KB

english, 2009

40

New agents for prostate cancer

Agarwal, N., Di Lorenzo, G., Sonpavde, G., Bellmunt, J.

Journal:

Annals of Oncology

Year:

2014

Language:

english

File:

PDF, 206 KB

english, 2014

41

Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy

Tilki, Derya, Shariat, Shahrokh F., Lotan, Yair, Rink, Michael, Karakiewicz, Pierre I., Schoenberg, Mark P., Lerner, Seth P., Sonpavde, Guru, Sagalowsky, Arthur I., Gupta, Amit

Journal:

BJU International

Year:

2013

Language:

english

File:

PDF, 175 KB

english, 2013

42

Activity of CEP-9722, a poly (ADP-ribose) polymerase inhibitor, in urothelial carcinoma correlates inversely with homologous recombination repair response to DNA damage

Jian, Weiguo, Xu, Hua-Guo, Chen, Jianfeng, Xu, Zhi-Xiang, Levitt, Jonathan M., Stanley, Jennifer A., Yang, Eddy S., Lerner, Seth P., Sonpavde, Guru

Journal:

Anti-Cancer Drugs

Year:

2014

Language:

english

File:

PDF, 708 KB

english, 2014

43

Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design

Sonpavde, Guru, Pond, Gregory R., Mullane, Stephanie, Qu, Angela Q., Di Lorenzo, Giuseppe, Federico, Piera, Necchi, Andrea, Rosenberg, Jonathan E., Bellmunt, Joaquim, Choueiri, Toni K.

Journal:

Clinical Genitourinary Cancer

Year:

2015

Language:

english

File:

PDF, 473 KB

english, 2015

44

Update of systemic immunotherapy for advanced urothelial carcinoma

Gartrell, Benjamin A., He, Tianfang, Sharma, Janaki, Sonpavde, Guru

Journal:

Urologic Oncology: Seminars and Original Investigations

Year:

2017

Language:

english

File:

PDF, 749 KB

english, 2017

45

Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer

Armstrong, A J, Lin, P, Higano, C S, Sternberg, C N, Sonpavde, G, Tombal, B, Templeton, A J, Fizazi, K, Phung, D, Wong, E K, Krivoshik, A, Beer, T M

Journal:

Annals of Oncology

Year:

2018

Language:

english

File:

PDF, 755 KB

english, 2018

46

A new subtyping model for residual invasive disease after cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer

Agarwal, Archana, Sonpavde, Guru

Journal:

Translational Andrology and Urology

Year:

2019

Language:

english

File:

PDF, 113 KB

english, 2019

47

A phase 3 study to evaluate enfortumab vedotin (EV) versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial cancer (la/mUC): EV-301, a trial-in-progress

Petrylak, D., Rosenberg, J., Duran, I., Loriot, Y., Sonpavde, G., Wu, C., Gartner, E., Melhem-Bertrandt, A., Powles, T.

Journal:

European Urology Supplements

Year:

2019

File:

PDF, 108 KB

2019

48

External Validation of the Association of Progression-Free Survival at 6 Months (PFS6) with Overall Survival at 12 Months (OS12) in Second-Line Therapy for Advanced Urothelial Carcinoma (UC)

Sonpavde, G., Maughan, B., Boucher, K.M., Fougeray, R., Choueiri, T.K., Niegisch, G., Wong, Y., Sridhar, S.S., Sternberg, C.N., Bellmunt, J.

Journal:

Annals of Oncology

Year:

2012

File:

PDF, 63 KB

2012

49

Treatment of metastatic urothelial cancer: opportunities for drug discovery and development

Guru Sonpavde, Cora N. Sternberg

Journal:

BJU International

Year:

2008

Language:

english

File:

PDF, 115 KB

english, 2008

50

Neoadjuvant systemic therapy for urological malignancies

Guru Sonpavde, Cora N. Sternberg

Journal:

BJU International

Year:

2010

Language:

english

File:

PDF, 583 KB

english, 2010

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски